Probiotics and antibiotic for SIBO in IBS patients
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether adding a probiotic supplement to standard antibiotic therapy (rifaximin) works better than the antibiotic alone for treating small intestinal bacterial overgrowth (SIBO) in people with irritable bowel syndrome (IBS). If you have IBS and SIBO, this study could help find a more effective treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have been diagnosed with irritable bowel syndrome (IBS) using the Rome IV criteria.
- You are willing to stop taking probiotics for at least 1 week before starting the study.
- You have not used antibiotics in the last 4 weeks.
- You have not had abdominal surgery.
- You do not have other digestive diseases like Crohn's disease, ulcerative colitis, or celiac disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an herbal supplement called Biocidin REMOVE can help treat bacterial overgrowth in the gut, which can cause bloating and other IBS symptoms. If you have IBS and a positive breath test for bacterial overgrowth, you might be able to join.
This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
This study tests whether probiotics (beneficial bacteria) can help reduce irritable bowel syndrome (IBS) symptoms and change certain markers in your gut. You'll take a probiotic supplement for 12 weeks while researchers track how your symptoms and gut health change.
This trial looks at whether an overgrowth of bacteria in the small intestine causes bloating. It tests how well treatment works for people with functional bloating (bloating without a clear cause) who also have this bacterial overgrowth.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
Hear when a new Small Intestinal Bacterial Overgrowth Syndrome (SIBO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.